Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1999 Mar;54(3):273–277. doi: 10.1136/thx.54.3.273

Treatment of pulmonary hypertension secondary to connective tissue diseases

O Sanchez 1, M Humbert 1, O Sitbon 1, G Simonneau 1
PMCID: PMC1745447  PMID: 10325906

Full Text

The Full Text of this article is available as a PDF (85.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpert M. A., Goldberg S. H., Singsen B. H., Durham J. B., Sharp G. C., Ahmad M., Madigan N. P., Hurst D. P., Sullivan W. D. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation. 1983 Dec;68(6):1182–1193. doi: 10.1161/01.cir.68.6.1182. [DOI] [PubMed] [Google Scholar]
  2. Alpert M. A., Pressly T. A., Mukerji V., Lambert C. R., Mukerji B., Panayiotou H., Sharp G. C. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol. 1991 Dec 15;68(17):1687–1691. doi: 10.1016/0002-9149(91)90330-n. [DOI] [PubMed] [Google Scholar]
  3. Alpert M. A., Pressly T. A., Mukerji V., Lambert C. R., Mukerji B. Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest. 1992 Nov;102(5):1407–1412. doi: 10.1378/chest.102.5.1407. [DOI] [PubMed] [Google Scholar]
  4. Asherson R. A., Cervera R. Review: antiphospholipid antibodies and the lung. J Rheumatol. 1995 Jan;22(1):62–66. [PubMed] [Google Scholar]
  5. Asherson R. A., Higenbottam T. W., Dinh Xuan A. T., Khamashta M. A., Hughes G. R. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol. 1990 Oct;17(10):1292–1298. [PubMed] [Google Scholar]
  6. Balagopal V. P., da Costa P., Greenstone M. A. Fatal pulmonary hypertension and rheumatoid vasculitis. Eur Respir J. 1995 Feb;8(2):331–333. doi: 10.1183/09031936.95.08020331. [DOI] [PubMed] [Google Scholar]
  7. Barst R. J., Rubin L. J., Long W. A., McGoon M. D., Rich S., Badesch D. B., Groves B. M., Tapson V. F., Bourge R. C., Brundage B. H. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996 Feb 1;334(5):296–301. doi: 10.1056/NEJM199602013340504. [DOI] [PubMed] [Google Scholar]
  8. Bjornsson J., Edwards W. D. Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc. 1985 Jan;60(1):16–25. doi: 10.1016/s0025-6196(12)65277-x. [DOI] [PubMed] [Google Scholar]
  9. Brentjens J., Ossi E., Albini B., Sepulveda M., Kano K., Sheffer J., Vasilion P., Marine E., Baliah T., Jockin H. Disseminated immune deposits in lupus erythematosus. Arthritis Rheum. 1977 May;20(4):962–968. doi: 10.1002/art.1780200408. [DOI] [PubMed] [Google Scholar]
  10. Bunch T. W., Tancredi R. G., Lie J. T. Pulmonary hypertension in polymyositis. Chest. 1981 Jan;79(1):105–107. doi: 10.1378/chest.79.1.105. [DOI] [PubMed] [Google Scholar]
  11. Dahl M., Chalmers A., Wade J., Calverley D., Munt B. Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy. J Rheumatol. 1992 Nov;19(11):1807–1809. [PubMed] [Google Scholar]
  12. Fahey P. J., Utell M. J., Condemi J. J., Green R., Hyde R. W. Raynaud's phenomenon of the lung. Am J Med. 1984 Feb;76(2):263–269. doi: 10.1016/0002-9343(84)90783-6. [DOI] [PubMed] [Google Scholar]
  13. Fuster V., Steele P. M., Edwards W. D., Gersh B. J., McGoon M. D., Frye R. L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984 Oct;70(4):580–587. doi: 10.1161/01.cir.70.4.580. [DOI] [PubMed] [Google Scholar]
  14. Gallerani M., Govoni M., Ricci L., Zanardi F., Percoco G., Toselli T., Trotta F. a 49-year-old woman with dyspnoea, palpitations and syncope. Int J Cardiol. 1996 Jul 5;55(1):67–78. doi: 10.1016/0167-5273(96)02658-7. [DOI] [PubMed] [Google Scholar]
  15. Glikson M., Pollack A., Dresner-Feigin R., Galun E., Rubinow A. Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome. Chest. 1990 Sep;98(3):759–761. doi: 10.1378/chest.98.3.759. [DOI] [PubMed] [Google Scholar]
  16. Goupille P., Fauchier L., Babuty D., Fauchier J. P., Valat J. P. Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus. J Rheumatol. 1994 Oct;21(10):1976–1977. [PubMed] [Google Scholar]
  17. Groen H., Bootsma H., Postma D. S., Kallenberg C. G. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol. 1993 Jun;20(6):1055–1057. [PubMed] [Google Scholar]
  18. Hosoda Y., Suzuki Y., Takano M., Tojo T., Homma M. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol. 1987 Aug;14(4):826–830. [PubMed] [Google Scholar]
  19. Hosoda Y., Suzuki Y., Takano M., Tojo T., Homma M. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol. 1987 Aug;14(4):826–830. [PubMed] [Google Scholar]
  20. Jolliet P., Thorens J. B., Chevrolet J. C. Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease. Thorax. 1995 Jan;50(1):96–97. doi: 10.1136/thx.50.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Karmochkine M., Wechsler B., Godeau P., Brenot F., Jagot J. L., Simonneau G. Improvement of severe pulmonary hypertension in a patient with SLE. Ann Rheum Dis. 1996 Aug;55(8):561–562. doi: 10.1136/ard.55.8.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Khamashta M. A., Cuadrado M. J., Mujic F., Taub N. A., Hunt B. J., Hughes G. R. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995 Apr 13;332(15):993–997. doi: 10.1056/NEJM199504133321504. [DOI] [PubMed] [Google Scholar]
  23. Levine S. M., Gibbons W. J., Bryan C. L., Walling A. D., Brown R. W., Bailey S. R., Cronin T., Calhoon J. P., Trinkle J. K., Jenkinson S. G. Single lung transplantation for primary pulmonary hypertension. Chest. 1990 Nov;98(5):1107–1115. doi: 10.1378/chest.98.5.1107. [DOI] [PubMed] [Google Scholar]
  24. Levy R. D., Guerraty A. J., Yacoub M. H., Loertscher R. Prolonged survival after heart-lung transplantation in systemic lupus erythematosus. Chest. 1993 Dec;104(6):1903–1905. doi: 10.1378/chest.104.6.1903. [DOI] [PubMed] [Google Scholar]
  25. McLaughlin V. V., Genthner D. E., Panella M. M., Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998 Jan 29;338(5):273–277. doi: 10.1056/NEJM199801293380501. [DOI] [PubMed] [Google Scholar]
  26. Morelli S., Giordano M., De Marzio P., Priori R., Sgreccia A., Valesini G. Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus. Lupus. 1993 Dec;2(6):367–369. doi: 10.1177/096120339300200606. [DOI] [PubMed] [Google Scholar]
  27. Morgan J. M., Griffiths M., du Bois R. M., Evans T. W. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest. 1991 Mar;99(3):551–556. doi: 10.1378/chest.99.3.551. [DOI] [PubMed] [Google Scholar]
  28. NAEYE R. L. PULMONARY VASCULAR LESIONS IN SYSTEMIC SCLERODERMA. Dis Chest. 1963 Oct;44:374–379. doi: 10.1378/chest.44.4.374. [DOI] [PubMed] [Google Scholar]
  29. Niarchos A. P., Whitman H. H., Goldstein J. E., Laragh J. H. Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease. Am Heart J. 1982 Oct;104(4 Pt 1):834–838. doi: 10.1016/0002-8703(82)90020-5. [DOI] [PubMed] [Google Scholar]
  30. O'Brien J. T., Hill J. A., Pepine C. J. Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis. Am Heart J. 1985 Feb;109(2):380–382. doi: 10.1016/0002-8703(85)90618-0. [DOI] [PubMed] [Google Scholar]
  31. Ocken S., Reinitz E., Strom J. Nifedipine treatment for pulmonary hypertension in a patient with systemic sclerosis. Arthritis Rheum. 1983 Jun;26(6):794–796. doi: 10.1002/art.1780260615. [DOI] [PubMed] [Google Scholar]
  32. Palevsky H. I., Schloo B. L., Pietra G. G., Weber K. T., Janicki J. S., Rubin E., Fishman A. P. Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation. 1989 Nov;80(5):1207–1221. doi: 10.1161/01.cir.80.5.1207. [DOI] [PubMed] [Google Scholar]
  33. Perez H. D., Kramer N. Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum. 1981 Aug;11(1):177–181. doi: 10.1016/0049-0172(81)90098-6. [DOI] [PubMed] [Google Scholar]
  34. Quismorio F. P., Jr, Sharma O., Koss M., Boylen T., Edmiston A. W., Thornton P. J., Tatter D. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum. 1984 May;13(4):349–359. doi: 10.1016/0049-0172(84)90015-5. [DOI] [PubMed] [Google Scholar]
  35. Ray J., Sermer M. Systemic lupus erythematosus and pulmonary hypertension during pregnancy: report of a case fatality. Can J Cardiol. 1996 Aug;12(8):753–756. [PubMed] [Google Scholar]
  36. Reitz B. A., Wallwork J. L., Hunt S. A., Pennock J. L., Billingham M. E., Oyer P. E., Stinson E. B., Shumway N. E. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982 Mar 11;306(10):557–564. doi: 10.1056/NEJM198203113061001. [DOI] [PubMed] [Google Scholar]
  37. Rich S., Dantzker D. R., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., Fishman A. P., Goldring R. M., Groves B. M., Koerner S. K. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987 Aug;107(2):216–223. doi: 10.7326/0003-4819-107-2-216. [DOI] [PubMed] [Google Scholar]
  38. Rich S., Kaufmann E., Levy P. S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992 Jul 9;327(2):76–81. doi: 10.1056/NEJM199207093270203. [DOI] [PubMed] [Google Scholar]
  39. Rubin L. A., Geran A., Rose T. H., Cohen H. A fatal pulmonary complication of lupus in pregnancy. Arthritis Rheum. 1995 May;38(5):710–714. doi: 10.1002/art.1780380521. [DOI] [PubMed] [Google Scholar]
  40. Rubin L. J., Groves B. M., Reeves J. T., Frosolono M., Handel F., Cato A. E. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation. 1982 Aug;66(2):334–338. doi: 10.1161/01.cir.66.2.334. [DOI] [PubMed] [Google Scholar]
  41. Rubin L. J. Primary pulmonary hypertension. N Engl J Med. 1997 Jan 9;336(2):111–117. doi: 10.1056/NEJM199701093360207. [DOI] [PubMed] [Google Scholar]
  42. Salerni R., Rodnan G. P., Leon D. F., Shaver J. A. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med. 1977 Apr;86(4):394–399. doi: 10.7326/0003-4819-86-4-394. [DOI] [PubMed] [Google Scholar]
  43. Sato T., Matsubara O., Tanaka Y., Kasuga T. Association of Sjögren's syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol. 1993 Feb;24(2):199–205. doi: 10.1016/0046-8177(93)90301-v. [DOI] [PubMed] [Google Scholar]
  44. Seibold J. R., Molony R. R., Turkevich D., Ruddy M. C., Kostis J. B. Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis. J Rheumatol. 1987 Jun;14(3):519–524. [PubMed] [Google Scholar]
  45. Shinohara S., Murata I., Yamada H., Sato T., Kikutani T., Inoue T., Ito K. Combined effects of diltiazem and oxygen in pulmonary hypertension of mixed connective tissue disease. J Rheumatol. 1994 Sep;21(9):1763–1765. [PubMed] [Google Scholar]
  46. Simonson J. S., Schiller N. B., Petri M., Hellmann D. B. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1989 Jul;16(7):918–925. [PubMed] [Google Scholar]
  47. Sitbon O., Brenot F., Denjean A., Bergeron A., Parent F., Azarian R., Herve P., Raffestin B., Simonneau G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):384–389. doi: 10.1164/ajrccm.151.2.7842196. [DOI] [PubMed] [Google Scholar]
  48. Sitbon O., Humbert M., Jagot J. L., Taravella O., Fartoukh M., Parent F., Herve P., Simonneau G. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J. 1998 Aug;12(2):265–270. doi: 10.1183/09031936.98.12020265. [DOI] [PubMed] [Google Scholar]
  49. Stupi A. M., Steen V. D., Owens G. R., Barnes E. L., Rodnan G. P., Medsger T. A., Jr Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986 Apr;29(4):515–524. doi: 10.1002/art.1780290409. [DOI] [PubMed] [Google Scholar]
  50. Sullivan W. D., Hurst D. J., Harmon C. E., Esther J. H., Agia G. A., Maltby J. D., Lillard S. B., Held C. N., Wolfe J. F., Sunderrajan E. V. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984 Mar;63(2):92–107. doi: 10.1097/00005792-198403000-00003. [DOI] [PubMed] [Google Scholar]
  51. Ungerer R. G., Tashkin D. P., Furst D., Clements P. J., Gong H., Jr, Bein M., Smith J. W., Roberts N., Cabeen W. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med. 1983 Jul;75(1):65–74. doi: 10.1016/0002-9343(83)91169-5. [DOI] [PubMed] [Google Scholar]
  52. Williamson D. J., Hayward C., Rogers P., Wallman L. L., Sturgess A. D., Penny R., Macdonald P. S. Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension. Circulation. 1996 Aug 1;94(3):477–482. doi: 10.1161/01.cir.94.3.477. [DOI] [PubMed] [Google Scholar]
  53. Yeo P. P., Sinniah R. Lupus cor pulmonale with electron microscope and immunofluroescent antibody studies. Ann Rheum Dis. 1975 Oct;34(5):457–460. doi: 10.1136/ard.34.5.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. de la Mata J., Gomez-Sanchez M. A., Aranzana M., Gomez-Reino J. J. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum. 1994 Oct;37(10):1528–1533. doi: 10.1002/art.1780371018. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES